NDC 0032-1203 – Creon

Pancrelipase Amylase 15000 [USP'U]/1; Pancrelipase Lipase 3000 [USP'U]/1; Pancrelipase Protease 9500 [USP'U]/1 · Capsule, Delayed Release · Oral

Human Prescription Drug 2 recalls

Product NDC0032-1203

Product details

Brand name
Creon
Generic name
Pancrelipase
Labeler
AbbVie Inc.
Dosage form
Capsule, Delayed Release
Route
Oral
Marketing category
BLA · BLA020725
Marketed since
April 30, 2009
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Creon →

Package NDC codes (2)

Package NDCDescriptionSince
0032-1203-64 sample1 BOTTLE in 1 CARTON (0032-1203-64) / 70 CAPSULE, DELAYED RELEASE in 1 BOTTLEApr 30, 2009
0032-1203-701 BOTTLE in 1 CARTON (0032-1203-70) / 70 CAPSULE, DELAYED RELEASE in 1 BOTTLEApr 30, 2009

Recalls mentioning this NDC

Other Creon products